Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Septerna, Inc. - Common Stock
(NQ:
SEPN
)
11.37
-0.03 (-0.26%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Septerna, Inc. - Common Stock
< Previous
1
2
Next >
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
June 23, 2025
Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases.
Via
Benzinga
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
June 23, 2025
Via
Benzinga
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
June 23, 2025
Via
Benzinga
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
June 23, 2025
Via
Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
May 29, 2025
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via
Investor's Business Daily
Analysts Think These Stocks Could More Than Double in Value
May 23, 2025
Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.
Via
MarketBeat
Topics
World Trade
Where Septerna Stands With Analysts
May 16, 2025
Via
Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
May 16, 2025
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.
Via
Benzinga
Topics
Government
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
May 16, 2025
Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains optimistic amid mixed signals.
Via
Benzinga
Which stocks have an unusual volume on Thursday?
May 15, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Is It Time to Buy the Dip in Novo Nordisk Stock?
May 15, 2025
Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing
Via
MarketBeat
Topics
Government
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
May 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 14, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
May 14, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Edges Higher; US Crude Oil Inventories Increase
May 14, 2025
Via
Benzinga
Topics
Stocks
Wednesday's pre-market session: top gainers and losers
May 14, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
May 14, 2025
Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases.
Via
Benzinga
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings
May 14, 2025
Via
Benzinga
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing
May 14, 2025
The deal is worth up to $2.2 billion, including more than $200 million in upfront and near-term payments.
Via
Investor's Business Daily
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled
May 14, 2025
Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other...
Via
Stocktwits
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 14, 2025
Via
Benzinga
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
March 14, 2025
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
February 18, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
February 18, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
February 18, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Tuesday's session: gap up and gap down stocks
February 18, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
US Stocks Mixed; NY State Business Activity Rises In February
February 18, 2025
Via
Benzinga
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 24, 2025
Via
Benzinga
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 22, 2025
Via
Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
January 22, 2025
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.